# DEFERASIROX

NDC: 59651-449
Generic name: DEFERASIROX
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20250908

FDA application: ANDA215137

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-449"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-449
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c220484e-1e6a-4a0c-a221-60223f3bc24c